NEOGENOMICS INC

For the period ended Dec 31, 2024. Filed Feb 18, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 18, 2025

NEO$16.96-3.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of December 31, 202 and

Table of Contents	NEOGENOMICS, INC.

(In thousands, except share and per share amounts)

	As of December 31,
	2024	2023
ASSETS
Current assets
Cash and cash equivalents	$367,012	$342,488
Marketable securities, at fair value	19,832	72,715
Accounts receivable, net	150,540	131,227
Inventories	26,748	24,156
Prepaid assets	20,165	17,987
Other current assets	11,722	8,239
Total current assets	596,019	596,812
Property and equipment (net of accumulated depreciation of $189,990 and $158,211, respectively)	94,103	92,012
Operating lease right-of-use assets	79,583	91,769
Intangible assets, net	339,681	373,128
Goodwill	522,766	522,766
Other assets	5,886	4,742
Total non-current assets	1,042,019	1,084,417
Total assets	$1,638,038	$1,681,229
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable	$21,607	$20,334
Accrued compensation	62,443	53,161
Accrued expenses and other liabilities	12,624	15,069
Current portion of operating lease liabilities	3,381	5,610
Current portion of convertible senior notes, net	200,777	—
Contract liabilities	409	2,130
Total current liabilities	301,241	96,304
Long-term liabilities
Operating lease liabilities	60,841	67,871
Convertible senior notes, net	340,335	538,198
Deferred income tax liabilities, net	21,510	24,285
Other long-term liabilities	11,772	13,034
Total long-term liabilities	434,458	643,388
Total liabilities	735,699	739,692
Commitments and contingencies (Note 14)
Stockholders’ equity
Common stock, $0.001 par value, (250,000,000 shares authorized; 128,145,333 and 127,369,142 shares issued and outstanding, respectively)	128	127
Additional paid-in capital	1,228,198	1,190,139
Accumulated other comprehensive loss	(206)	(1,674)
Accumulated deficit	(325,781)	(247,055)
Total stockholders’ equity	902,339	941,537
Total liabilities and stockholders’ equity	$1,638,038	$1,681,229

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.